Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HLA-DMB |
| Upstream (Parents) |
|---|
| (<<) HLA-DRA → HLA-DMB |
| (<<) CYBB → HLA-DMB |
| (<<) HLA-DMA → HLA-DMB |
| (<<) CD86 → HLA-DMB |
| Downstream (Children) |
|---|
| HLA-DMB → CXCL9 (>>) |
| HLA-DMB → FABP4 (>>) |
| HLA-DMB → ICOS (>>) |
| HLA-DMB → PDCD1LG2 (>>) |
| HLA-DMB → CECR1 (>>) |
| HLA-DMB → CD40 (>>) |
| HLA-DMB → CARD9 (>>) |
| HLA-DMB → HLA-DPB1 (>>) |
| HLA-DMB → SLAMF7 (>>) |
| HLA-DMB → HLA-DRA (>>) |
| HLA-DMB → SLC15A3 (>>) |
| HLA-DMB → CD2 (>>) |
| HLA-DMB → CD74 (>>) |
| HLA-DMB → CFD (>>) |
| HLA-DMB → PLA2G7 (>>) |
| HLA-DMB → BTN3A3 (>>) |
| HLA-DMB → CCL4 (>>) |
| HLA-DMB → AKR1B1 (>>) |
| HLA-DMB → HLA-DMA (>>) |
| HLA-DMB → SASH3 (>>) |
| HLA-DMB → VAV1 (>>) |
